IP Library › Granted Patent US 10,066,257
Granted Patent B2
US 10,066,257 · App. 13/474,596 · Granted Sep 4, 2018

Methods and compositions for detecting target nucleic acids

Inventors: Robert Terbrueggen (Manhattan Beach, CA); Yenbou Liu (Arcadia, CA); John Ray Childers, Jr. (Long Beach, CA); Chang Hee Kim (Rancho Palos Verdes, CA); Majid R. Abedi (Rancho Cucamonga, CA)
Assignee: DXTERITY DIAGNOSTICS INCORPORATED
C12Q1/6813C12Q1/6809C12Q1/6834C12Q1/6855C12Q1/6862
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,066,257
App. No.
13/474,596
Granted
Sep 4, 2018
Kind
B2
Abstract

The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.

Claims (33)

1. A method of detecting a plurality of different target nucleic acids in a target sample, wherein each target nucleic acid comprises an adjacent first and a second target domain, said method comprising:

a) providing a reaction mixture comprising said target sample in lysis buffer comprising 2 to 6 molar guanidinium salt;

b) contacting said reaction mixture with a plurality of different probes sets, each probe set comprising:

i) a first nucleic acid ligation probe comprising:

1) a first probe domain complementary to a first target domain of said one a target nucleic acid;

2) a first primer sequence; and

3) a 5′-ligation moiety; and

ii) a second nucleic acid ligation probe comprising:

1) a second probe domain complementary to a second target domain of said one target nucleic acid;

2) a second primer sequence; and

3) a 3′ ligation moiety;

wherein one of said first or second nucleic acid ligation probes comprises a detectable label and the other comprises one of a binding partner pair;

c) ligating said first and second ligation probes in the absence of a ligase enzyme to form a plurality of different ligation products;

d) contacting said ligation products with a solid support comprising the other of said binding partner pair such that said ligation products are captured on said solid support;

e) washing said solid support;

f) amplifying said different ligation products; and

g) detecting the presence of said ligation products.

2. A method according to claim 1 wherein said detectable label comprises a variable spacer sequence and said plurality of different probe sets have different length variable spacer sequences.

3. A method according to claim 2 , wherein said detecting is done using said variable spacer sequence.

4. A method according to claim 1 wherein said target nucleic acids are RNA.

5. A method according to claim 1 wherein one of said first and second ligation probes further comprises one of a binding partner pair, and prior to said amplifying, a bead comprising the other of the binding pair is added to capture said ligated products.

6. The method of claim 1 , wherein said 5′ ligation moiety is a thioester and said 3′ ligation moiety is a nucleophile.

7. The method of claim 1 , wherein said 5′ ligation moiety is a nucleophile and said 3′ ligation moiety is a thioester.

8. The method of claim 1 , wherein said 5′ ligation moiety is a DABSYL moiety and said 3′ ligation moiety is a phosphorothioate moiety.

9. The method of claim 1 , wherein said 5′ ligation moiety is a phosphorothioate moiety and said 3′ ligation moiety is a DABSYL moiety.

10. A method according to claim 1 wherein said guanidinium salt is guanidinium hydrochloride.

11. A method according to claim 1 wherein said guanidinium salt is guanidinium isothiocyanate.

12. A method according to claim 1 wherein said guanidinium salt is 3M guanidinium hydrochloride.

13. A method according to claim 1 wherein said detectable label is a fluorophore.

14. A method according to claim 1 wherein said capture support comprises beads.

15. A method according to claim 14 wherein said beads are magnetic beads.

16. A method according to claim 15 wherein said binding partner pair comprises biotin and streptavidin.

17. A method according to claim 16 wherein said biotin is attached to one of said ligation probes.

Assignments (5)
SECURITY INTEREST Recorded Jul 10, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 036061/0144 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: SILICON VALLEY BANK
To: DXTERITY DIAGNOSTICS
Reel/Frame 035438/0992 →
SECURITY INTEREST Recorded Apr 17, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SWK FUNDING LLC
Reel/Frame 035439/0279 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 031156/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2012
From: TERBRUEGGEN, ROBERT; LIU, YENBOU; CHILDERS, JR., JOHN RAY; KIM, CHANG HEE; ABEDI, MAJID R.
To: DXTERITY DIAGNOSTICS INCORPORATED
Reel/Frame 028911/0472 →
Continuity (3)
Continuation In Part 12798108 · Mar 29, 2010
Provisional Application 61486817 · May 17, 2011
Related Publication 20130005594A1 · Jan 3, 2013